Status:
RECRUITING
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Psychosis
Suicide
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
People with psychotic disorders are excluded from most suicide-focused clinical trials despite incredibly high rates of completed suicide, and interventions that have been tested for this population h...
Eligibility Criteria
Inclusion
- At least 18 years old
- Psychosis spectrum disorder as assessed by the Mini International Neuropsychiatric Interview (MINI) for Psychotic Disorder Studies
- Heightened suicide risk as determined by a score of 8+ on the Suicide Behaviors Questionnaire-Revised (SBQ-R). This cutoff may be revised downwards (toward lower suicide risk) if recruitment appears difficult, but will not be revised upwards.
- Enrollment and engagement in outpatient mental health services with at least one mental health service in the previous month
- 6+ grade equivalent reading level as assessed by the Wide Range Achievement Test 4 (WRAT-4)
Exclusion
- Chart diagnosis of intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness.
Key Trial Info
Start Date :
December 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT05440214
Start Date
December 2 2022
End Date
December 30 2026
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland
Baltimore, Maryland, United States, 21201